Since pancreatic cancer cells maintain intracellular levels of nutrients via pathways of both autophagy and macropinocytosis, REP1-mediated autophagy regulation could be a potential therapeutic target for treating pancreatic cancer. The gene discussed is CHM; the disease is pancreatic neoplasm.